B. Dohmen

511 total citations
21 papers, 355 citations indexed

About

B. Dohmen is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, B. Dohmen has authored 21 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in B. Dohmen's work include Medical Imaging Techniques and Applications (7 papers), Medical Imaging and Pathology Studies (3 papers) and Testicular diseases and treatments (3 papers). B. Dohmen is often cited by papers focused on Medical Imaging Techniques and Applications (7 papers), Medical Imaging and Pathology Studies (3 papers) and Testicular diseases and treatments (3 papers). B. Dohmen collaborates with scholars based in Germany, Pakistan and United States. B. Dohmen's co-authors include Roland Bares, Carsten Bokemeyer, Lothar Kanz, Claus D. Claussen, S. Eschmann, Frank Paulsen, Wilfried Budach, U. Cremerius, Karin Oechsle and Godehard Friedel and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

B. Dohmen

21 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Dohmen Germany 10 160 151 113 51 51 21 355
Şeyma Yıldız Türkiye 12 134 0.8× 133 0.9× 100 0.9× 92 1.8× 32 0.6× 39 426
Eun Ji Han South Korea 12 153 1.0× 178 1.2× 129 1.1× 52 1.0× 17 0.3× 46 425
Gonca Kara Gedi̇k Türkiye 10 135 0.8× 131 0.9× 167 1.5× 13 0.3× 57 1.1× 60 419
Lise Bettman Israel 9 135 0.8× 303 2.0× 157 1.4× 50 1.0× 47 0.9× 12 551
Ramesh Asopa India 12 188 1.2× 153 1.0× 88 0.8× 17 0.3× 25 0.5× 31 395
SHIN-HWA YEH Taiwan 11 188 1.2× 159 1.1× 160 1.4× 16 0.3× 15 0.3× 50 444
Fabian Steinkohl Austria 11 160 1.0× 106 0.7× 115 1.0× 25 0.5× 26 0.5× 28 382
Jang Yoo South Korea 12 112 0.7× 165 1.1× 67 0.6× 16 0.3× 27 0.5× 41 332
Wynnie Wai Man Lam Hong Kong 8 230 1.4× 135 0.9× 93 0.8× 35 0.7× 111 2.2× 10 514
John J. Pagani United States 10 134 0.8× 62 0.4× 86 0.8× 25 0.5× 31 0.6× 23 304

Countries citing papers authored by B. Dohmen

Since Specialization
Citations

This map shows the geographic impact of B. Dohmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Dohmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Dohmen more than expected).

Fields of papers citing papers by B. Dohmen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Dohmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Dohmen. The network helps show where B. Dohmen may publish in the future.

Co-authorship network of co-authors of B. Dohmen

This figure shows the co-authorship network connecting the top 25 collaborators of B. Dohmen. A scholar is included among the top collaborators of B. Dohmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Dohmen. B. Dohmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wit, Maike de, Winfried Brenner, Michael Hartmann, et al.. (2008). [18F]-FDG–PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial. Annals of Oncology. 19(9). 1619–1623. 55 indexed citations
3.
Solbach, Christoph, Marianne Patt, Matthias Reimold, et al.. (2007). [11C]Vinblastine syntheses and preliminary imaging in cancer patients.. PubMed. 10(2). 266s–276s. 2 indexed citations
4.
Unger, J., et al.. (2006). Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH—an in vitro study. Nephrology Dialysis Transplantation. 21(8). 2191–2201. 14 indexed citations
5.
Unger, J., B. Dohmen, Axel M. Gressner, et al.. (2005). Albumin and hydroxyethyl starch 130 kDa/0.4 improve filter clearance and haemocompatibility in haemo- and plasmafiltration—an in vitro study. Nephrology Dialysis Transplantation. 20(9). 1922–1931. 10 indexed citations
6.
Oechsle, Karin, C. Kollmannsberger, B. Dohmen, et al.. (2004). [18F]FDG-PET, CT/MRT und Tumormarker als prädiktive Indikatoren für das Ansprechen unter Hochdosis-Chemotherapie bei Patienten mit metastasierten Keimzelltumoren. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 176(1). 76–84. 9 indexed citations
7.
Reimold, Matthias, et al.. (2004). Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves. European Journal of Nuclear Medicine and Molecular Imaging. 31(4). 564–577. 8 indexed citations
8.
Krauss, Katja, et al.. (2004). Value of Positron Emission Tomography Scan in Staging Cancers, and an Unusual Presentation of Acute Myeloid Leukemia. Journal of Clinical Oncology. 22(14). 2966–2968. 2 indexed citations
10.
Bokemeyer, Carsten, Christian Kollmannsberger, Karin Oechsle, et al.. (2002). Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET. British Journal of Cancer. 86(4). 506–511. 53 indexed citations
11.
Eschmann, S., Godehard Friedel, Frank Paulsen, et al.. (2002). FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 29(6). 804–808. 55 indexed citations
13.
Albes, J.M., et al.. (2002). Value of positron emission tomography for lung cancer staging. European Journal of Surgical Oncology. 28(1). 55–62. 13 indexed citations
14.
Unger, J., et al.. (2002). The Influence of HES on the Filtration Properties of Capillary Membrane Plasmaseparation. The International Journal of Artificial Organs. 25(8). 798–805. 1 indexed citations
15.
Wiskirchen, Jakub, Helmut Dittmann, Wolfgang Schöber, et al.. (2001). Dosisabhängige Auswirkungen des kombinierten β/γ Emitters Rhenium186 auf das Wachstum humaner Gefäßwandzellen*. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 173(1). 72–76. 3 indexed citations
16.
Dittmann, Helmut, Martin Sökler, C. Kollmannsberger, et al.. (2001). Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma. Oncology Reports. 8(6). 1393–9. 55 indexed citations
17.
Manz, Markus G., Reimer Rießen, L. Poll, et al.. (2001). High‐grade lymphoma mimicking bone crisis in Gaucher's disease. British Journal of Haematology. 113(1). 191–193. 8 indexed citations
18.
Schreckenberger, M., Gudrun Wagenknecht, Hedwig J. Kaiser, et al.. (1998). Bestimmung von Einflußgrößen für den Therapieerfolg der Radioiodtherapie bei Patienten mit Morbus Basedow. Nuklearmedizin - NuclearMedicine. 37(3). 83–89. 7 indexed citations
20.
Grün, Barbara, et al.. (1995). KST und Onkoszintigraphie mit 99mTc-MIBI in der Nachsorge des Schilddrüsenkarzinoms. Nuklearmedizin - NuclearMedicine. 34(3). 87–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026